Rectal Optical Markers for in Vivo Risk Stratification of Premalignant Colorectal Lesions

Clinical Cancer Research

Volumn 21, Issue 19, 2015, Pages 4347-4355

  Radosevic, Andrew J ^a   Mutyal, Nikhil N ^a   Eshein, Adam ^a   Nguyen, The Quyen ^a   Gould, Bradley ^a   Rogers, Jeremy D ^b   Goldberg, Michael J ^c   Bianchi, Laura K ^c   Yen, Eugene F ^c   Konda, Vani ^d   Rex, Douglas K ^e   Van Dam, Jacques ^f   Backman, Vadim ^a   Roy, Hemant K ^g  

^a Northwestern University   (United States)

^b University of Wisconsin Madison   (United States)

^c NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^d UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f LAC USC MEDICAL CENTER   (United States)

^g BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADENOMA; ADULT; AGED; ANALYSIS OF COVARIANCE; AREA UNDER THE CURVE; ARTICLE; BIOMASS DISTRIBUTION; CALIBRATION; COLON ADENOMA; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DYSPLASIA; FEMALE; FIBER OPTICS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LOGISTIC REGRESSION ANALYSIS; LOW COHERENCE ENHANCED BACKSCATTERING SPECTROSCOPY; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE PROCEDURE; MONTE CARLO METHOD; MULTIPLE NON ADVANCED ADENOMA; PILOT STUDY; POPULATION RESEARCH; PRECANCER; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SPECTROSCOPY; TUMOR VOLUME; ULTRASTRUCTURE; BIOPSY; CANCER STAGING; CASE CONTROL STUDY; COLONIC NEOPLASMS; DEVICES; EARLY CANCER DIAGNOSIS; EPIDEMIOLOGY; INTESTINE MUCOSA; MIDDLE AGED; PATHOLOGY; POINT OF CARE SYSTEM; PRECANCEROUS CONDITIONS; PROCEDURES; RECTUM; REPRODUCIBILITY;

ADENOMA; AGED; BIOMARKERS; BIOPSY; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; CONFOUNDING FACTORS (EPIDEMIOLOGY); CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NEOPLASM STAGING; POINT-OF-CARE SYSTEMS; PRECANCEROUS CONDITIONS; RECTUM; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTRUM ANALYSIS;

EID: 84945967448     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-15-0136     Document Type: Article

References (39)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015:65:5-29.
2. Siegel RL, Ward EM, Jemal A. Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiol Biomarkers Prev 2012;21:411-6.
3. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58:130-60.
4. Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 2014;370:1287-97.
5. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationaleUpdate based on new evidence. Gastroenterology 2003;124:544-60.
6. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704-14.
7. Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007;99:1462-70.
8. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953;6:963-8.
9. Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, et al. MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 2005;97:1330-8.
10. Franklin WA, Gazdar AF, Haney J, Wistuba II, La Rosa FG, Kennedy T, et al. Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J Clin Invest 1997;100: 2133-7.
11. Mehrotra J, Varde S, Wang H, Chiu H, Vargo J, Gray K, et al. Quantitative, spatial resolution of the epigenetic field effect in prostate cancer. Prostate 2008;68:152-60.
12. Prevo LJ, Sanchez CA, Galipeau PC, Reid BJ. p53-mutant clones and field effects in Barrett's esophagus. Cancer Res 1999;59:4784-7.
13. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003;63:1727-30.
14. Dakubo GD, Jakupciak JP, Birch-Machin MA, Parr RL. Clinical implications and utility of field cancerization. Cancer Cell Int 2007;7:2.
15. Stypula-Cyrus Y, Damania D, Kunte DP, Cruz MD, Subramanian H, Roy HK, et al. HDAC up-regulation in early colon field carcinogenesis is involved in cell tumorigenicity through regulation of chromatin structure. PLoS ONE 2013;8:e64600.
16. Stypula-Cyrus Y, Mutyal NN, Dela Cruz M, Kunte DP, Radosevich AJ, Wali R, et al. End-binding protein 1 (EB1) up-regulation is an early event in colorectal carcinogenesis. FEBS Lett 2014:588:829-35.
17. Backman V, Roy HK. Advances in biophotonics detection of field carci-nogenesis for colon cancer risk stratification. J Cancer 2013;4:251-61.
18. Cherkezyan L, Stypula-Cyrus Y, Subramanian H, White C, Dela Cruz M, Wali RK, et al. Nanoscale changes in chromatin organization represent the initial steps of tumorigenesis: a transmission electron microscopy study. BMC Cancer 2014;14:189.
19. Lewis JD, Ng K, Hung KE, Bilker WB, Berlin JA, Brensinger C, et al. Detection of proximal adenomatous polyps with screening sigmoidoscopy: a systematic review and meta-analysis of screening colonoscopy. Arch Intern Med 2003;163:413-20.
20. Roy HK, Turzhitsky V, Gomes A, Goldberg MJ, Rogers JD, Kim YL, et al. Prediction of colonic neoplasia through spectral marker analysis from the endoscopically normal rectum: an ex vivo and in vivo study. Gastroenter-ology 2008;134:A109-A.
21. Roy HK, Turzhitsky V, Kim Y, Goldberg MJ, Watson P, Rogers JD, et al. Association between rectal optical signatures and colonic neo-plasia: potential applications for screening. Cancer Res 2009;69: 4476-83.
22. Radosevich AJ, Mutyal NN, Yi J, Stypula-Cyrus Y, Rogers JD, Goldberg MJ, et al. Ultrastructural alterations in field carcinogenesis measured by enhanced backscattering spectroscopy. J Biomed Opt 2013;18.
23. Yi J, Radosevich AJ, Stypula-Cyrus Y, Mutyal NN, Azarin SM, Horcher E, et al. Spatially resolved optical and ultrastructural properties of colorectal and pancreatic field carcinogenesis observed by inverse spectroscopic optical coherence tomography. J Biomed Opt 2014;19:36013.
24. Subramanian H, Roy HK, Pradhan P, Goldberg MJ, Muldoon J, Brand RE, et al. Nanoscale cellular changes in field carcinogenesis detected by partial wave spectroscopy. Cancer Res 2009;69:5357-63.
25. Gomes AJ, Roy HK, Turzhitsky V, Kim Y, Rogers JD, Ruderman S, et al. Rectal mucosal microvascular blood supply increase is associated with colonic neoplasia. Clin Cancer Res 2009;15:3110-7.
26. Turzhitsky VM, Gomes AJ, Kim YL, Liu Y, Kromine A, Rogers JD, et al. Measuring mucosal blood supply in vivo with a polarization-gating probe. Appl Opt 2008;47:6046-57.
27. Kim YL, Liu Y, Wali RK, Roy HK, Backman V. Low-coherent backscattering spectroscopy for tissue characterization. Appl Opt 2005;44:366-77.
28. Radosevich AJ, Yi J, Rogers JD, Backman V. Structural length-scale sensitivities of reflectance measurements in continuous random media under the Born approximation. Opt Lett 2012;37: 5220-2.
29. Rogers JD, Radosevich AJ, Ji Y, Backman V. Modeling light scattering in tissue as continuous random media using a versatile refractive index correlation function. Selected Topics in Quantum Electronics, IEEE Journal of 2014;20:1-14.
30. Mutyal NN, Radosevich A, Gould B, Rogers JD, Gomes A, Turzhitsky V, et al. A fiber optic probe design to measure depth-limited optical properties in-vivo with low-coherence enhanced backscattering (LEBS) spectroscopy. Opt Express 2012;20:19643-57.
31. Rogers JD, Stoyneva V, Turzhitsky V, Mutyal NN, Pradhan P, Capoglu IR, et al. Alternate formulation of enhanced backscattering as phase conjugation and diffraction: derivation and experimental observation. Opt Exp 2011;19:11922-31.
32. Turzhitsky V, Mutyal NN, Radosevich AJ, Backman V. Multiple scattering model for the penetration depth of low-coherence enhanced backscatter-ing. J Biomed Opt 2011;16:097006.
33. Radosevich AJ, Rogers JD, Turzhitsky V, Mutyal NN, Yi J, Roy HK, et al. Polarized enhanced backscattering spectroscopy for characterization of biological tissues at subdiffusion length scales. IEEE J Sel Top Quant 2012;18:1313-25.
34. Rogers JD, Capoglu IR, Backman V. Nonscalar elastic light scattering from continuous random media in the Born approximation. Opt Lett 2009;34:1891-3.
35. Turzhitsky V, Radosevich AJ, Rogers JD, Mutyal NN, Backman V. Measurement of optical scattering properties with low-coherence enhanced back-scattering spectroscopy. J Biomed Opt 2011;16:067007.
36. Cheong WF, Prahl SA, Welch AJ. A review of the optical-properties of biological tissues. IEEE J Quantum Elect 1990;26:2166-85.
37. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
38. Zink D, Fischer AH, Nickerson JA. Nuclear structure in cancer cells. Nat Rev Cancer 2004;4:677-87.
39. van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006;101:343-50.